Shiyong Li
Overview
Explore the profile of Shiyong Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
2092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia G, Yang X, Yu Y, Li Y, Zhang Z, Tang X, et al.
Mol Brain
. 2025 Mar;
18(1):17.
PMID: 40033442
Following intracerebral hemorrhage, mitigating oxidative stress and removing excess iron are critical strategies for reducing secondary brain injury and improving neurological outcomes. In vitro, we synthesized quercetin-ethylenediamine carbon quantum dots...
2.
Marin E, Abousaud A, Davis K, Sumrall B, Li S, Langston A, et al.
EJHaem
. 2025 Feb;
6(1):e270001.
PMID: 39944794
Brentuximab vedotin (BV) is a drug that has improved outcomes in classical Hodgkin lymphoma (cHL). However, its safety and efficacy in patients living with HIV who present with severe liver...
3.
Li S, Wei Y, Li H
Polymers (Basel)
. 2025 Feb;
17(3).
PMID: 39940622
Biodegradable polymer drug-loaded vascular stents are a typical and promising application in the field of invasive interventional therapy. The drug release process of drug-loaded vascular stents, as well as the...
4.
Geng S, Li S, Wu W, Chang Y, Mao M
Cancer Res Commun
. 2024 Dec;
5(1):150-156.
PMID: 39740056
Large-scale screening inevitably leads to significant financial burdens on the healthcare system, which is a key factor constraining nationwide screenings. The two-step MCED approach not only maintains comparable performance but...
5.
Ren Q, Li S, Zhong G, Li Y, Huang D, Zhang L, et al.
Cancer Med
. 2024 Dec;
13(24):e70511.
PMID: 39704423
Background And Purpose: Liver cancer has a high recurrence rate of 50%~70% for early-stage patients. Minimal residual disease (MRD) is strongly linked to liver cancer early recurrence. Identifying MRD through...
6.
Ji X, Liu S, Li S, Li X, Luo A, Zhang X, et al.
Int J Dev Neurosci
. 2024 Nov;
84(8):843-856.
PMID: 39503050
This comprehensive review examines the multifaceted roles of gamma-aminobutyric acid (GABA) in early brain development. GABA, traditionally recognized for its inhibitory functions in the mature brain, also exhibits excitatory effects...
7.
Zhou B, Li S, Luo A, Zheng H
Heliyon
. 2024 Oct;
10(19):e38349.
PMID: 39391505
Background: Although remimazolam tosilate is an ultra-short-acting benzodiazepine that causes less respiratory and circulatory depression than propofol, studies evaluating its efficacy and safety during endoscopic retrograde cholangiopancreatography (ERCP) are limited....
8.
Wei S, Wang Z, Li S, Ren H, Wang Y, Xiao H, et al.
Talanta
. 2024 Sep;
282:126961.
PMID: 39342668
Developing immunosensing platforms capable of simultaneously detecting multiple cancer markers is crucial for clinical diagnosis and biomedical research. Here, we introduce a novel dual-mode electrochemical biosensing assay platform capable of...
9.
Du H, Liu W, Li Y, Zhang L, Jiang F, Zhu D, et al.
BMC Res Notes
. 2024 Sep;
17(1):264.
PMID: 39272211
Objective: Cancer is currently the most common cause of death in adult dogs. Like humans, dogs have a one-third chance of developing cancer in their lifetime. We used shallow whole-genome...
10.
Que M, Li S, Xia Q, Li X, Luo X, Zhan G, et al.
Neurobiol Dis
. 2024 Aug;
200:106627.
PMID: 39111702
An increasing number of people undergo anesthesia and surgery. Perioperative neurocognitive and depressive disorders are common central nervous system complications with similar pathogeneses. These conditions pose a deleterious threat to...